Japan Patient-derived Xenograft Model Market Size & Outlook

The patient-derived xenograft model market in Japan is expected to reach a projected revenue of US$ 21.7 million by 2030. A compound annual growth rate of 12.4% is expected of Japan patient-derived xenograft model market from 2025 to 2030.
Revenue, 2024 (US$M)
$10.8
Forecast, 2030 (US$M)
$21.7
CAGR, 2025 - 2030
12.4%
Report Coverage
Japan

Japan patient-derived xenograft model market, 2018-2030 (US$M)

Japan

Related Markets

Japan patient-derived xenograft model market highlights

  • The Japan patient-derived xenograft model market generated a revenue of USD 10.8 million in 2024 and is expected to reach USD 21.7 million by 2030.
  • The Japan market is expected to grow at a CAGR of 12.3% from 2025 to 2030.
  • In terms of segment, breast cancer was the largest revenue generating tumor type in 2024.
  • Lung Cancer is the most lucrative tumor type segment registering the fastest growth during the forecast period.

Patient-derived xenograft model market data book summary

Market revenue in 2024USD 10.8 million
Market revenue in 2030USD 21.7 million
Growth rate12.3% (CAGR from 2024 to 2030)
Largest segmentBreast cancer
Fastest growing segmentLung Cancer
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationLung Cancer, Pancreatic Cancer, Prostrate Cancer, Breast Cancer, Other Cancer
Key market players worldwideCharles River Laboratories International Inc, The Jackson Laboratory, Crown Holdings Inc, Inotiv Inc, Wuxi AppTec Co Ltd, OncoCyte Corp, Alteogen, XenTech, Abnova

Other key industry trends

  • In terms of revenue, Japan accounted for 3.7% of the global patient-derived xenograft model market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China patient-derived xenograft model market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 33.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Patient-derived Xenograft Model Market Companies

Name Profile # Employees HQ Website

Japan patient-derived xenograft model market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to patient-derived xenograft model market will help companies and investors design strategic landscapes.


Breast cancer was the largest segment with a revenue share of 31.48% in 2024. Horizon Databook has segmented the Japan patient-derived xenograft model market based on lung cancer, pancreatic cancer, prostrate cancer, breast cancer, other cancer covering the revenue growth of each sub-segment from 2018 to 2030.


  • Japan Patient-derived Xenograft Model Tumor Type Outlook (Revenue, USD Million, 2018-2030)
    • Lung Cancer
    • Pancreatic Cancer
    • Prostrate Cancer
    • Breast Cancer
    • Other Cancer
  • Japan Patient-derived Xenograft Model Model Type Outlook (Revenue, USD Million, 2018-2030)
    • Mice Model
    • Rat Model
  • Japan Patient-derived Xenograft Model End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical and Biopharmaceutical Companies
    • Accademic and Research Institutes
    • CROs and CDMOs

Reasons to subscribe to Japan patient-derived xenograft model market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan patient-derived xenograft model market databook

  • Our clientele includes a mix of patient-derived xenograft model market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan patient-derived xenograft model market , including forecasts for subscribers. This country databook contains high-level insights into Japan patient-derived xenograft model market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan patient-derived xenograft model market size, by tumor type, 2018-2030 (US$M)

Japan Patient-derived Xenograft Model Market Outlook Share, 2024 & 2030 (US$M)

Japan patient-derived xenograft model market size, by tumor type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more